Skip to main content
SpringerLink
Log in

The Role of Inflammation in Cervical Cancer

  • Chapter
  • First Online:
Book cover Inflammation and Cancer

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 816))

Abstract

Knowledge regarding cervical cancer and human papillomavirus is expanding rapidly. Inflammation subsequent to viral infection is a driving force that accelerates cancer development. The infiltrated immune cells and their secretory cytokines along with chemokines and growth factors greatly contribute the malignant traits of cervical cancer. A better understanding of the mechanisms related to inflammation and cancer progression in terms of pathogen survival, cancer development, progression, and metastasis will lead to innovative approach for treating cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Tahhan MA, Etewa RL, el Behery MM (2011) Association between circulating interleukin-1 beta (IL-1beta) levels and IL-1beta C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 353:159–165

    Article  CAS  PubMed  Google Scholar 

  • Ashrafi GH, Haghshenas MR, Marchetti B, O’Brien PM, Campo MS (2005) E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 113:276–283

    Article  CAS  PubMed  Google Scholar 

  • Baker R, Dauner JG, Rodriguez AC, Williams MC, Kemp TJ, Hildesheim A, Pinto LA (2011) Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. Cytokine 53:282–285

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Barbisan G, Perez LO, Contreras A, Golijow CD (2012) TNF-alpha and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol 33:1549–1556

    Article  CAS  PubMed  Google Scholar 

  • Basile JR, Zacny V, Munger K (2001) The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J Biol Chem 276:22522–22528

    Article  CAS  PubMed  Google Scholar 

  • Bodily JM, Mehta KP, Laimins LA (2011) Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res 71:1187–1195

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chang YE, Laimins LA (2000) Microarray analysis identifies interferon-inducible genes and stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol 74:4174–4182

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z (2009) Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 15:400–405

    Article  CAS  PubMed  Google Scholar 

  • Chiantore MV, Vannucchi S, Accardi R, Tommasino M, Percario ZA, Vaccari G, Affabris E, Fiorucci G, Romeo G (2012) Interferon-beta induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity. PLoS One 7:e36909

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Coleman MP, Quaresma M, Berrino F, Lutz JM, de Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Ga ES, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9:730–756

    Article  PubMed  Google Scholar 

  • Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C (2012) On behalf of the Esmo guidelines working group 2012. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23, vii27–vii32

    Google Scholar 

  • Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081

    Article  CAS  PubMed  Google Scholar 

  • de Marco F, Bucaj E, Foppoli C, Fiorini A, Blarzino C, Filipi K, Giorgi A, Schinina ME, di Domenico F, Coccia R, Butterfield DA, Perluigi M (2012) Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One 7:e34366

    Article  PubMed Central  PubMed  Google Scholar 

  • Decarlo CA, Severini A, Edler L, Escott NG, Lambert PF, Ulanova M, Zehbe I (2010) IFN-kappa, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes. Lab Invest 90:1482–1491

    Article  CAS  PubMed  Google Scholar 

  • Degregori J, Johnson DG (2006) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6:739–748

    CAS  PubMed  Google Scholar 

  • Ding B, Fu S, Wang M, Yue C, Wang W, Zhou D, Zhang Z, Han S (2012) Tumor necrosis factor alpha -308 G > A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 22:213–219

    Article  PubMed  Google Scholar 

  • Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK (2011) Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11:39–44

    Article  PubMed  Google Scholar 

  • Du M, Fan X, Hong E, Chen JJ (2002) Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem Biophys Res Commun 296:962–969

    Article  CAS  PubMed  Google Scholar 

  • Duenas-Gonzalez A, Cetina L, Coronel J, Cervantes-Madrid D (2012) Emerging drugs for cervical cancer. Expert Opin Emerg Drugs 17:203–218

    Article  CAS  PubMed  Google Scholar 

  • Duensing S, Munger K (2003) Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 77:12331–12335

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Duensing A, Liu Y, Tseng M, Malumbres M, Barbacid M, Duensing S (2006) Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 25:2943–2949

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Feng Q, Wei H, Morihara J, Stern J, Yu M, Kiviat N, Hellstrom I, Hellstrom KE (2012) Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol 127:412–419

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ferlay J, Parkin DM, Steliarova-Foucher E (2010a) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010b) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917

    Article  CAS  PubMed  Google Scholar 

  • Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ (2002) The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem 277:21730–21739

    Article  CAS  PubMed  Google Scholar 

  • Filippova M, Parkhurst L, Duerksen-Hughes PJ (2004) The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J Biol Chem 279:25729–25744

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald DW, Bezak K, Ocheretina O, Riviere C, Wright TC, Milne GL, Zhou XK, Du B, Subbaramaiah K, Byrt E, Goodwin ML, Rafii A, Dannenberg AJ (2012) The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels. Cancer Prev Res (Phila) 5:34–40

    Article  CAS  Google Scholar 

  • Gaiotti D, Chung J, Iglesias M, Nees M, Baker PD, Evans CH, Woodworth CD (2000) Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol Carcinog 27:97–109

    Article  CAS  PubMed  Google Scholar 

  • Gangwar R, Mittal B, Mittal RD (2009) Association of interleukin-6-174G > C promoter polymorphism with risk of cervical cancer. Int J Biol Markers 24:11–16

    CAS  PubMed  Google Scholar 

  • Garland SM, Bhatla N, Ngan HY (2012) Cervical cancer burden and prevention strategies: Asia Oceania perspective. Cancer Epidemiol Biomarkers Prev 21:1414–1422

    Article  PubMed  Google Scholar 

  • Garnett TO, Duerksen-Hughes PJ (2006) Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol 151:2321–2335

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Garnett TO, Filippova M, Duerksen-Hughes PJ (2006) Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ 13:1915–1926

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, Munroe DJ, Farrar WL (2005) Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 65:4673–4682

    Article  CAS  PubMed  Google Scholar 

  • Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375–1382

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129–4135

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, Lee HP (2007) Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 22:110–113

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436

    Article  CAS  PubMed  Google Scholar 

  • Kemp TJ, Hildesheim A, Garcia-Pineres A, Williams MC, Shearer GM, Rodriguez AC, Schiffman M, Burk R, Freer E, Bonilla J, Herrero R, Pinto LA (2010) Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 19:1954–1959

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, Ono M (2004) Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 18:300–310

    Article  CAS  PubMed  Google Scholar 

  • Lammens T, Li J, Leone G, de Veylder L (2009) Atypical E2Fs: new players in the E2F transcription factor family. Trends Cell Biol 19:111–118

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lee TS, Jeon YT, Kim JW, Park NH, Kang SB, Lee HP, Song YS (2007) Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population. Ann N Y Acad Sci 1095:134–142

    Article  CAS  PubMed  Google Scholar 

  • Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y, Kim J, Park J, Park S, Hong J, Yoon DY (2011) Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 132:410–420

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ma S, Tang J, Feng J, Xu Y, Yu X, Deng Q, Lu Y (2008) Induction of p21 by p65 in p53 null cells treated with Doxorubicin. Biochim Biophys Acta 1783:935–940

    Article  CAS  PubMed  Google Scholar 

  • McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ (1997) Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 15:265–274

    Article  CAS  PubMed  Google Scholar 

  • Okamoto T, Sanda T, Asamitsu K (2007) NF-kappa B signaling and carcinogenesis. Curr Pharm Des 13:447–462

    Article  CAS  PubMed  Google Scholar 

  • Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, Mittal RD (2011) Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 38:4715–4721

    Article  CAS  PubMed  Google Scholar 

  • Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275:6764–6769

    Article  CAS  PubMed  Google Scholar 

  • Patel D, Huang SM, Baglia LA, McCance DJ (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18:5061–5072

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Poljak M (2012) Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges. Clin Microbiol Infect 18(Suppl 5):64–69

    Article  PubMed  Google Scholar 

  • Reiser J, Hurst J, Voges M, Krauss P, Munch P, Iftner T, Stubenrauch F (2011) High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol 85:11372–11380

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, Bachmann A, Ritter TM, Dondog B, Ly R, Bosch FX, Zawatzky R, Rosl F (2009) Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Cancer Res 69:8718–8725

    Article  CAS  PubMed  Google Scholar 

  • Ronco LV, Karpova AY, Vidal M, Howley PM (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–2072

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sankaranarayanan (2011) Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction. IARC Sci Publ, pp 1–5

    Google Scholar 

  • Sasagawa T, Takagi H, Makinoda S (2012) Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother 18:807–815

    Article  CAS  PubMed  Google Scholar 

  • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890–907

    Article  CAS  PubMed  Google Scholar 

  • Shekari M, Kordi-Tamandani DM, Malekzadeh K, Sobti RC, Karimi S, Suri V (2012) Effect of anti-inflammatory (IL-4, IL-10) cytokine genes in relation to risk of cervical carcinoma. Am J Clin Oncol 35:514–519

    Article  CAS  PubMed  Google Scholar 

  • Singh H, Sachan R, Goel H, Mittal B (2008) Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG 115:633–638

    Article  CAS  PubMed  Google Scholar 

  • Singh H, Jain M, Sachan R, Mittal B (2009) Association of TNFA (-308G > A) and IL-10 (-819C > T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 19:1190–1194

    Article  PubMed  Google Scholar 

  • Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre-Garau X, Couturier J, Mosseri V, Vives V, Banchereau J, Fridman WH, Wijdenes J, Lebecque S, Sautes-Fridman C (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 59:3698–3704

    CAS  PubMed  Google Scholar 

  • Wang Q, Zhang C, Walayat S, Chen HW, Wang Y (2011) Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol 158:330–333

    Article  CAS  PubMed  Google Scholar 

  • Wang N, Yin D, Zhang S, Wei H, Wang S, Zhang Y, Lu Y, Dai S, Li W, Zhang Q (2012) TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS One 7:e45246

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S (2004) Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23:3550–3560

    Article  CAS  PubMed  Google Scholar 

  • Zhou F, Leggatt GR, Frazer IH (2011) Human papillomavirus 16 E7 protein inhibits interferon-gamma-mediated enhancement of keratinocyte antigen processing and T-cell lysis. FEBS J 278:955–963

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India

    S. Deivendran, K Hezlin Marzook & M. Radhakrishna Pillai

Authors
  1. S. Deivendran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Hezlin Marzook
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Radhakrishna Pillai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Radhakrishna Pillai .

Editor information

Editors and Affiliations

  1. Dept of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Bharat B. Aggarwal

  2. Dept of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Bokyung Sung

  3. Dep Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Subash Chandra Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Basel

About this chapter

Cite this chapter

Deivendran, S., Marzook, K.H., Radhakrishna Pillai, M. (2014). The Role of Inflammation in Cervical Cancer. In: Aggarwal, B., Sung, B., Gupta, S. (eds) Inflammation and Cancer. Advances in Experimental Medicine and Biology, vol 816. Springer, Basel. https://doi.org/10.1007/978-3-0348-0837-8_15

Download citation

Publish with us

Policies and ethics

Search

Navigation